AGL 40.21 Increased By ▲ 0.18 (0.45%)
AIRLINK 127.64 Decreased By ▼ -0.06 (-0.05%)
BOP 6.67 Increased By ▲ 0.06 (0.91%)
CNERGY 4.45 Decreased By ▼ -0.15 (-3.26%)
DCL 8.73 Decreased By ▼ -0.06 (-0.68%)
DFML 41.16 Decreased By ▼ -0.42 (-1.01%)
DGKC 86.11 Increased By ▲ 0.32 (0.37%)
FCCL 32.56 Increased By ▲ 0.07 (0.22%)
FFBL 64.38 Increased By ▲ 0.35 (0.55%)
FFL 11.61 Increased By ▲ 1.06 (10.05%)
HUBC 112.46 Increased By ▲ 1.69 (1.53%)
HUMNL 14.81 Decreased By ▼ -0.26 (-1.73%)
KEL 5.04 Increased By ▲ 0.16 (3.28%)
KOSM 7.36 Decreased By ▼ -0.09 (-1.21%)
MLCF 40.33 Decreased By ▼ -0.19 (-0.47%)
NBP 61.08 Increased By ▲ 0.03 (0.05%)
OGDC 194.18 Decreased By ▼ -0.69 (-0.35%)
PAEL 26.91 Decreased By ▼ -0.60 (-2.18%)
PIBTL 7.28 Decreased By ▼ -0.53 (-6.79%)
PPL 152.68 Increased By ▲ 0.15 (0.1%)
PRL 26.22 Decreased By ▼ -0.36 (-1.35%)
PTC 16.14 Decreased By ▼ -0.12 (-0.74%)
SEARL 85.70 Increased By ▲ 1.56 (1.85%)
TELE 7.67 Decreased By ▼ -0.29 (-3.64%)
TOMCL 36.47 Decreased By ▼ -0.13 (-0.36%)
TPLP 8.79 Increased By ▲ 0.13 (1.5%)
TREET 16.84 Decreased By ▼ -0.82 (-4.64%)
TRG 62.74 Increased By ▲ 4.12 (7.03%)
UNITY 28.20 Increased By ▲ 1.34 (4.99%)
WTL 1.34 Decreased By ▼ -0.04 (-2.9%)
BR100 10,086 Increased By 85.5 (0.85%)
BR30 31,170 Increased By 168.1 (0.54%)
KSE100 94,764 Increased By 571.8 (0.61%)
KSE30 29,410 Increased By 209 (0.72%)

This is a public limited company incorporated in the province of Sindh having its registered office and manufacturing facilities located at B-2 S.I.T.E. Karachi. The company was listed at Karachi Stock Exchange in 1983. As per note annexed with the accounts under review, it is informed that the company together with the Pfizer Laboratories Ltd, (PLL) jointly petitioned the Honourable High Court of Sindh and prayed, inter-alia, that the company be amalgamated with PLL.
Based on the Honourable Court order fresh valuation as at 31st December 2002 was conducted and the valuation report submitted to the Honourable Court. It has been also stated in the Note.
"The minority shareholders of PLL have challenged such report and the matter is yet pending final evaluation".
Another Note reported that the company has policy whereby purchases from related parties Pfizer Corporation, Pharma (the parent company) and its affiliated companies are entered into arm's length prices using "transactional margin method".
It has been also reported that the company has entered into executive, marketing, medical, financial, but man resource service agreement with Pfizer Laboratories Ltd (PLL) and into a general services agreement with Pharmacia Pakistan (Private) Ltd.
There functions of the companies have been pooled and costs are shared by each company under "Cost plus method" based on management's estimate of utilisation of such services.
The company has also entered into a toll manufacturing agreement with PLL. The toll manufacturing charges have been determined under "comparable uncontrolled price" (CUP) method based on the toll manufacturing charges to unrelated parties by affiliated companies less directly attributable costs borne by PLL to facilitate the production of its goods.
During the half year under review the company's sales at Rs 594.50 million, Gross Profit at Rs 269.11 million and operating profit at Rs 166.77 million showed increased over related figures in the corresponding period of last year by 4.9%, 3.2% and 12.6% respectively. Gross margin was slightly lower.
Other income was nearly three times. Net Profit after taxation was 26% higher at Rs 152.48 million over Rs 126.91 million in the HY 2003-04.
The closing price of its share on 6/12/04 was recorded at Rs 900 per share which is 90 times of the par value. The company has highly attractive profit distribution profile. During the last two yearly the dividend pay-outs were at 250 percent per year. The growth in sales is mainly due to volume sales.



======================================================
Performance Statistics (Million Rupees)
======================================================
Balance sheet -As At-
======================================================
June 30 December 31
2004 2003
======================================================
Share Capital-Paid-up: 19.58 19.58
Reserves & Profit: 1,176.28 1,023.81
Shareholders Equity: 1,195.86 1,043.39
Deferred Liabilities: 66.10 62.34
Current Liabilities: 233.05 154.16
Fixed Assets: 247.03 251.52
L T Loans: 1.98 2.36
L.T Deposits: 1.18 1.25
Current Liabilities: 1,244.82 1,004.76
Total Assets: 1,495.01 1,259.89
------------------------------------------------------
Profit & Loss A/c For the
Half Year Ended June 30 2004 2003
------------------------------------------------------
Sales-Net: 594.50 566.62
Gross Profit: 269.11 260.84
Operating Profit: 166.77 148.15
Financial (Charges): (2.67) (1.38)
Other Income: 28.94 10.81
Profit Before Taxation: 183.06 149.41
Profit After Taxation: 152.48 126.91
Earning Per Share (Rs): 77.86 64.80
Share Price (Rs) on 6/12/04: 900.00 -
Price/Earning Ratio: 11.56 -
Book Value of Share (Rs): 610.75 532.86
Debt/Equity Ratio: 0:100 0:100
Current Ratio: 5.34 6.52
Gross Profit Margin (%): 45.27 46.03
Net Profit Margin (%): 25.65 22.39
R O A (%): 10.20 10.07
======================================================

COMPANY INFORMATION: Chairman & Chief Executive: Iqbal Bengali; Director: Abdul Majeed: Company Secretary: S.M. Wajeehuddin; Registered Office & Factory: B-2 S.I.T.E Karachi-75700; Web Address: Not Reported.
Copyright Business Recorder, 2004

Comments

Comments are closed.